BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23315986)

  • 21. Targeting the Mitochondrial Genome Via a MITO-Porter : Evaluation of mtDNA and mtRNA Levels and Mitochondrial Function.
    Yamada Y; Harashima H
    Methods Mol Biol; 2021; 2275():227-245. PubMed ID: 34118041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a Mitochondrial Targeting Lipid Nanoparticle Encapsulating Berberine.
    Hori I; Harashima H; Yamada Y
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial Delivery of an Anticancer Drug Via Systemic Administration Using a Mitochondrial Delivery System That Inhibits the Growth of Drug-Resistant Cancer Engrafted on Mice.
    Yamada Y; Munechika R; Satrialdi ; Kubota F; Sato Y; Sakurai Y; Harashima H
    J Pharm Sci; 2020 Aug; 109(8):2493-2500. PubMed ID: 32376272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mitochondrial DDS Opens Innovative Pharmaceutics].
    Yamada Y
    Yakugaku Zasshi; 2016; 136(1):55-62. PubMed ID: 26725668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases.
    Yamada Y; Harashima H
    Adv Drug Deliv Rev; 2008; 60(13-14):1439-62. PubMed ID: 18655816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient Total Synthesis of Bongkrekic Acid and Apoptosis Inhibitory Activity of Its Analogues.
    Matsumoto K; Suyama M; Fujita S; Moriwaki T; Sato Y; Aso Y; Muroshita S; Matsuo H; Monda K; Okuda K; Abe M; Fukunaga H; Kano A; Shindo M
    Chemistry; 2015 Aug; 21(32):11590-602. PubMed ID: 26126659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted mitochondrial delivery of antisense RNA-containing nanoparticles by a MITO-Porter for safe and efficient mitochondrial gene silencing.
    Kawamura E; Hibino M; Harashima H; Yamada Y
    Mitochondrion; 2019 Nov; 49():178-188. PubMed ID: 31472283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [MITO-Porter; a cutting-edge technology for mitochondrial gene therapy].
    Furukawa R; Yamada Y; Harashima H
    Yakugaku Zasshi; 2012; 132(12):1389-98. PubMed ID: 23208046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical role of mitochondria, but not caspases, during glucocorticosteroid-induced human eosinophil apoptosis.
    Létuvé S; Druilhe A; Grandsaigne M; Aubier M; Pretolani M
    Am J Respir Cell Mol Biol; 2002 May; 26(5):565-71. PubMed ID: 11970908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of a MITO-Porter to deliver exogenous therapeutic RNA to a mitochondrial disease's cell with a A1555G mutation in the mitochondrial 12S rRNA gene results in an increase in mitochondrial respiratory activity.
    Yamada Y; Maruyama M; Kita T; Usami SI; Kitajiri SI; Harashima H
    Mitochondrion; 2020 Nov; 55():134-144. PubMed ID: 33035688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial amplification of death signals determines thymidine kinase/ganciclovir-triggered activation of apoptosis.
    Beltinger C; Fulda S; Kammertoens T; Uckert W; Debatin KM
    Cancer Res; 2000 Jun; 60(12):3212-7. PubMed ID: 10866313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Packaging of the Coenzyme Q
    Yamada Y; Burger L; Kawamura E; Harashima H
    Biol Pharm Bull; 2017; 40(12):2183-2190. PubMed ID: 29199241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of the mitochondrial permeability transition mediates the killing of HeLa cells by staurosporine.
    Tafani M; Minchenko DA; Serroni A; Farber JL
    Cancer Res; 2001 Mar; 61(6):2459-66. PubMed ID: 11289115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial transgene expression via an artificial mitochondrial DNA vector in cells from a patient with a mitochondrial disease.
    Ishikawa T; Somiya K; Munechika R; Harashima H; Yamada Y
    J Control Release; 2018 Mar; 274():109-117. PubMed ID: 29408532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of the Nanoparticulation Method and Cell-Killing Effect following the Mitochondrial Delivery of Hydrophobic Porphyrin-Based Photosensitizers.
    Naganawa R; Zhao H; Takano Y; Maeki M; Tokeshi M; Harashima H; Yamada Y
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of apoptosis by valinomycin: mitochondrial permeability transition causes intracellular acidification.
    Furlong IJ; Lopez Mediavilla C; Ascaso R; Lopez Rivas A; Collins MK
    Cell Death Differ; 1998 Mar; 5(3):214-21. PubMed ID: 10200467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. α-Synuclein overexpression impairs mitochondrial function by associating with adenylate translocator.
    Zhu Y; Duan C; Lü L; Gao H; Zhao C; Yu S; Uéda K; Chan P; Yang H
    Int J Biochem Cell Biol; 2011 May; 43(5):732-41. PubMed ID: 21310263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced autophagy induction via the mitochondrial delivery of methylated β-cyclodextrin-threaded polyrotaxanes using a MITO-Porter.
    Yamada Y; Daikuhara S; Tamura A; Nishida K; Yui N; Harashima H
    Chem Commun (Camb); 2019 Jun; 55(50):7203-7206. PubMed ID: 31165120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the Mitochondrial Delivery of Vitamin B
    Yamada Y; Ishimaru T; Ikeda K; Harashima H
    J Pharm Sci; 2022 Feb; 111(2):432-439. PubMed ID: 34478755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Betanodavirus induces phosphatidylserine exposure and loss of mitochondrial membrane potential in secondary necrotic cells, both of which are blocked by bongkrekic acid.
    Chen SP; Yang HL; Her GM; Lin HY; Jeng MF; Wu JL; Hong JR
    Virology; 2006 Apr; 347(2):379-91. PubMed ID: 16430940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.